-
November 13, 2026
A health advocacy group and three dietary supplement sellers urged a D.C. federal judge Friday to rule the U.S. Food and Drug Administration overstepped when it rejected over a hundred label claims for supplement products that connected certain nutrients to health outcomes.
-
November 13, 2026
A Texas technology company has sued OpenAI, claiming it is infringing a set of patents covering artificial intelligence attention, the same day it sued Anthropic on similar claims.
-
November 13, 2026
The Federal Trade Commission sought Friday to block Covetrus Inc.'s planned $3.5 billion purchase of "its closest competitor" for veterinary products, MWI Veterinary Supply Inc., in a New York federal court complaint backed by more than a dozen state attorneys general.
-
November 12, 2026
Nonprofits sued Anthropic, Google, Meta Platforms, OpenAI and SpaceXSI in California state court Thursday seeking to freeze the "insane" and "dangerous" development of advanced artificial intelligence that can escape human control, arguing the companies have no realistic way to stop the "catastrophic" events their own executives predict could occur.
-
November 12, 2026
Masimo Corp. and the U.S. International Trade Commission said Thursday that the U.S. Supreme Court should ignore Apple's arguments that the Federal Circuit degraded the agency's domestic industry requirement by sustaining a finding that Apple watches infringed a pair of patents.
-
November 12, 2026
U.S. Patent and Trademark Office Director John Squires has instituted five new patent challenges, largely in the pharmaceutical industry, in one of his final mass orders.
-
November 12, 2026
School district plaintiffs on Wednesday opposed a bid by YouTube, Snap and Meta to exclude late-disclosed witnesses from an upcoming bellwether trial in social media addiction multidistrict litigation, noting that defendant TikTok agreed the school district witnesses can be added if TikTok USDS Joint Venture's new CEO can testify as well.
-
November 12, 2026
A Texas technology company sued Anthropic on Thursday claiming it was infringing a set of patents covering AI attention for training when working on its marquee chatbot model Claude.
-
November 12, 2026
A former employee at Cravath Swaine & Moore LLP on Thursday was arrested and charged with insider trading for allegedly exploiting nonpublic information about major deals involving the firm's clients, including Paramount Skydance Corp.'s $110 billion acquisition of Warner Bros. Discovery Inc.
-
November 10, 2026
Dog owners on Monday told a Washington federal judge that Costco's bid to dismiss their proposed class action alleging that its grain-free dog food contributes to canine heart disease ignores their factual allegations, saying that the company is cherry-picking from studies about the risk.
-
November 10, 2026
Verrica Pharmaceuticals and a group of investors have reached a $4 million deal to end claims that the company hid obstacles it faced in obtaining U.S. Food and Drug Administration approval for its lead product.
-
November 10, 2026
A Los Angeles dispensary placed "malicious" code in marketing emails that spied on a consumer and recorded when she opened the messages and her location, forwarding the information to data-broker vendors, according to a California state lawsuit which seeks $1,000 per email and $5,000 per privacy violation.
-
November 10, 2026
An Idaho federal judge on Tuesday stayed his finding that the state would violate the 14th Amendment by criminalizing certain abortions performed by a doctor challenging the state's abortion laws, saying he is bound by a Ninth Circuit decision he "strongly disagrees" with.
-
November 10, 2026
Drugmaker Skye Bioscience Inc. has reached a $2.5 million settlement with investors that would end a proposed securities class action alleging the company overhyped a weight-loss drug, causing its stock price to plummet once the truth came to light.
-
November 10, 2026
The U.S. Tax Court improperly imposed additional accuracy-related penalties against a Florida business for deductions it took for microcaptive insurance expenses, the business's owner told the Eleventh Circuit, saying the Tax Court's analysis of the case can't be reconciled with binding circuit precedent.
-
November 10, 2026
A medical device company failed to provide Washington hourly workers with required meal and rest breaks, underpaid their wages and restricted their ability to discuss their pay, according to a proposed class action removed to Washington federal court.
-
November 10, 2026
Health intelligence platform Oura, advised by Latham & Watkins LLP, on Tuesday unveiled plans to acquire artificial intelligence-native primary care company Counsel Health, led by DLA Piper, in a $625 million deal.
-
November 10, 2026
The Pennsylvania state judge overseeing Philadelphia's Zantac mass tort litigation has again rejected claims that he might have a conflict of interest because his wife's firm represents a defendant in one of more than 500 such cases, pointing out that the case in question has been resolved.
-
November 10, 2026
A New Jersey bankruptcy judge on Tuesday denied the Office of the U.S. Trustee's bid to convert Invatech's bankruptcy to a Chapter 7 as the former generic pharmaceutical group works to wrap up an administratively insolvent Chapter 11.
-
November 10, 2026
A Massachusetts federal judge said Tuesday she will reduce an $88 million verdict awarded to an Alabama couple in the first bellwether hernia mesh trial against Medtronic subsidiary Covidien LP, saying the award appeared to be "the product of passion."
-
November 09, 2026
A Federal Circuit judge on Monday appeared perplexed by medical aesthetics provider Medytox Inc.'s position that the U.S. International Trade Commission wrongly rejected its claim that a rival stole its anti-wrinkle technology, saying Medytox's argument "has nothing to do" with the ruling.
-
November 09, 2026
The Ninth Circuit has set aside a judgment directing Research Development Foundation to pay royalties to Pacira Pharmaceuticals Inc. in a contract dispute involving the anesthetic Exparel, further remanding the case for a recalculation of prejudgment interest.
-
November 09, 2026
The attorney general of Ohio is seeking to amend its complaint accusing Express Scripts and several related entities of conspiring to raise prescription drug prices.
-
November 09, 2026
The U.S. Food and Drug Administration on Monday said it is requiring new warnings on GLP-1 medications, the group of blockbuster drugs prescribed for diabetes and weight loss, for a serious, rare condition that can cause sudden and possibly permanent vision loss in one eye.
-
November 09, 2026
Pharmaceutical company Compass Pathways announced Monday that it had submitted to the U.S. Food and Drug Administration a new drug application to treat treatment-resistant depression with psilocybin, the primary compound in psychoactive mushrooms.